MEDIVIR AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.13 SEK | +0.64% |
|
+0.97% | +9.82% |
| 05-07 | Medivir Aktiebolag Approves Board Appointments | CI |
| 04-30 | Transcript : Medivir AB, Q1 2024 Earnings Call, Apr 30, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MEDIVIR AB | Bio Therapeutic Drugs | +0.64% | +0.97% | +9.82% | -57.30% | -83.26% | 33.11M |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- MVIR B Stock
- Charts Medivir AB
- Comparison Chart
